These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16763062)
1. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Martin JL; Jambazov S Endocrinology; 2006 Sep; 147(9):4400-9. PubMed ID: 16763062 [TBL] [Abstract][Full Text] [Related]
2. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Arai T; Busby W; Clemmons DR Endocrinology; 1996 Nov; 137(11):4571-5. PubMed ID: 8895319 [TBL] [Abstract][Full Text] [Related]
3. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Conover CA; Khosla S Growth Horm IGF Res; 2003 Dec; 13(6):328-35. PubMed ID: 14624766 [TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor (IGF)-I stimulates cell proliferation and induces IGF binding protein (IGFBP)-3 and IGFBP-5 gene expression in cultured growth plate chondrocytes via distinct signaling pathways. Kiepe D; Ciarmatori S; Hoeflich A; Wolf E; Tönshoff B Endocrinology; 2005 Jul; 146(7):3096-104. PubMed ID: 15845624 [TBL] [Abstract][Full Text] [Related]
5. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Hollier BG; Kricker JA; Van Lonkhuyzen DR; Leavesley DI; Upton Z Endocrinology; 2008 Mar; 149(3):1075-90. PubMed ID: 18079201 [TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor binding protein-2 by MCF-7 breast cancer cells is regulated through the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway. Martin JL; Baxter RC Endocrinology; 2007 May; 148(5):2532-41. PubMed ID: 17289850 [TBL] [Abstract][Full Text] [Related]
8. Structural and functional characteristics of the Val44Met insulin-like growth factor I missense mutation: correlation with effects on growth and development. Denley A; Wang CC; McNeil KA; Walenkamp MJ; van Duyvenvoorde H; Wit JM; Wallace JC; Norton RS; Karperien M; Forbes BE Mol Endocrinol; 2005 Mar; 19(3):711-21. PubMed ID: 15576456 [TBL] [Abstract][Full Text] [Related]
9. Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. Nam TJ; Busby WH; Rees C; Clemmons DR Endocrinology; 2000 Mar; 141(3):1100-6. PubMed ID: 10698186 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780. Chan TW; Pollak M; Huynh H Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Burrows C; Holly JM; Laurence NJ; Vernon EG; Carter JV; Clark MA; McIntosh J; McCaig C; Winters ZE; Perks CM Endocrinology; 2006 Jul; 147(7):3484-500. PubMed ID: 16614079 [TBL] [Abstract][Full Text] [Related]
15. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells. Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546 [TBL] [Abstract][Full Text] [Related]
16. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism. Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Russo VC; Schütt BS; Andaloro E; Ymer SI; Hoeflich A; Ranke MB; Bach LA; Werther GA Endocrinology; 2005 Oct; 146(10):4445-55. PubMed ID: 15994346 [TBL] [Abstract][Full Text] [Related]
18. Mitogenic properties of insulin-like growth factors I and II, insulin-like growth factor binding protein-3 and epidermal growth factor on human breast stromal cells in primary culture. Strange KS; Wilkinson D; Edin G; Emerman JT Breast Cancer Res Treat; 2004 Mar; 84(2):77-84. PubMed ID: 14999138 [TBL] [Abstract][Full Text] [Related]
19. Intrinsic actions of IGFBP-3 and IGFBP-5 on Hs578T breast cancer epithelial cells: inhibition or accentuation of attachment and survival is dependent upon the presence of fibronectin. McCaig C; Perks CM; Holly JM J Cell Sci; 2002 Nov; 115(Pt 22):4293-303. PubMed ID: 12376561 [TBL] [Abstract][Full Text] [Related]
20. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation. Huynh H; Chow PK; Ooi LL; Soo KC Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]